Clinical efficacy of electroacupuncture-like magnetic therapy compared to conventional transcutaneous electrical nerve stimulation in individuals with carpal tunnel syndrome.
Sui-Foon LoLi-Wei ChouHuynh ChungHsiu-Chen LinPublished in: Scientific reports (2023)
This study aimed to evaluate the clinical efficacy of an electroacupuncture-like magnetic therapy (ELMT) and conventional transcutaneous electrical nerve stimulation (TENS) in patients with carpal tunnel syndrome (CTS). A prospective randomized controlled trial in single-centre was conducted. Thirty-four CTS patients confirmed by electrodiagnostic study were randomized into TENS or ELMT group and completed a six-week treatment program. TENS or ELMT treatment was applied on acupuncture point PC-6 (Neiguan) and one selected hand acupoint. Therapeutic exercises were also included after the electrophysical modality. Their physical signs, motor and sensory performances, Boston Carpal Tunnel Questionnaire (BCTQ) scores, and results of electrodiagnostic study were evaluated. After treatments, both groups demonstrated significantly decreased BCTQ scores and positive rate of Tinel's sign in the major symptomatic side, which indicated improvements in the symptom severity and physical functions. Significant increases in distal sensory amplitude and nerve conduction velocity of the median nerve were only found in the ELMT group. Our study found either conventional TENS or ELMT plus therapeutic exercises could improve the symptomatology and physical provocation sign of CTS. The ELMT has additional improvement in the nerve conduction in patients with CTS.
Keyphrases
- randomized controlled trial
- physical activity
- mental health
- stem cells
- end stage renal disease
- chronic kidney disease
- mesenchymal stem cells
- spinal cord
- ejection fraction
- study protocol
- double blind
- brain injury
- placebo controlled
- blood flow
- newly diagnosed
- body composition
- functional connectivity
- quality improvement
- blood brain barrier
- subarachnoid hemorrhage
- patient reported
- cross sectional
- molecularly imprinted
- phase iii